Search by Drug Name or NDC
NDC 00025-2732-31 Norpace CR 100 mg/1 Details
Norpace CR 100 mg/1
Norpace CR is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is DISOPYRAMIDE PHOSPHATE.
MedlinePlus Drug Summary
Disopyramide is used to treat certain types of irregular heartbeats). Disopyramide is in a class of medications called antiarrhythmic medications. It works by making your heart more resistant to abnormal activity.
Related Packages: 00025-2732-31Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Disopyramide
Product Information
| NDC | 00025-2732 |
|---|---|
| Product ID | 0025-2732_bad34f2f-efbc-453a-b783-fba7a05ba580 |
| Associated GPIs | 35100010106910 |
| GCN Sequence Number | 000241 |
| GCN Sequence Number Description | disopyramide phosphate CAPSULE ER 100 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 01140 |
| HICL Sequence Number | 000077 |
| HICL Sequence Number Description | DISOPYRAMIDE PHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | Norpace CR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | disopyramide phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | DISOPYRAMIDE PHOSPHATE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018655 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00025-2732-31 (00025273231)
| NDC Package Code | 0025-2732-31 |
|---|---|
| Billing NDC | 00025273231 |
| Package | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2732-31) |
| Marketing Start Date | 1982-07-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |